Nanopharmacology focuses on the design, development, and application of nanoscale materials for medical purposes. At the intersection of nanotechnology and pharmacology, this discipline harnesses the unique properties of nanoparticles to revolutionize drug delivery and therapeutic interventions. Nanoparticles, often ranging in size from 1 to 100 nanometers, offer distinct advantages such as increased surface area, enhanced bioavailability, and targeted delivery to specific cells or tissues. In the realm of pharmaceuticals, nanopharmacology holds the promise of overcoming challenges associated with conventional drug delivery systems, including poor solubility and systemic side effects.
By precisely manipulating the physicochemical properties of nanoparticles, researchers aim to optimize drug formulations, improve therapeutic efficacy, and minimize adverse reactions. This field's potential extends beyond drug delivery, as nanopharmacology also explores diagnostic applications and personalized medicine, showcasing its transformative impact on the future of healthcare. As scientists delve deeper into understanding the intricate interactions at the nanoscale, nanopharmacology emerges as a frontier with vast implications for advancing pharmaceutical science and patient care.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico